However, many constraints remain on how SDM is utilized in clinical practice [20], similar to the situation encountered in the clinical diagnosis and treatment of papillary thyroid cancer and patients treated with growth hormone [21, 22]. The gene discussed is GH1; the disease is thyroid gland papillary carcinoma.